Merck KGaA
MKGAF
$129.45
-$4.45-3.32%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.80% | 7.39% | 3.53% | -0.03% | 2.67% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.80% | 7.39% | 3.53% | -0.03% | 2.67% |
| Cost of Revenue | 5.71% | 5.49% | 10.87% | -1.96% | -1.25% |
| Gross Profit | 5.87% | 8.68% | -1.27% | 1.32% | 5.71% |
| SG&A Expenses | 12.13% | 10.11% | 5.02% | 0.22% | 13.09% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 79.00% | -220.46% | -58.98% | 49.14% | -305.95% |
| Total Operating Expenses | 17.20% | 4.51% | 0.93% | -1.12% | -8.86% |
| Operating Income | -27.25% | 18.36% | 18.47% | 4.85% | 62.11% |
| Income Before Tax | -45.94% | 14.50% | 11.35% | 3.08% | 25.12% |
| Income Tax Expenses | -39.94% | 3.58% | 1.93% | 5.66% | 161.55% |
| Earnings from Continuing Operations | -47.19% | 17.61% | 14.16% | 2.35% | 12.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -82.01% | 241.79% | -258.16% | 41.84% | -48.52% |
| Net Income | -47.77% | 18.57% | 13.26% | 2.67% | 12.70% |
| EBIT | -27.25% | 18.36% | 18.47% | 4.85% | 62.11% |
| EBITDA | -4.96% | 15.49% | 12.67% | 3.59% | 22.99% |
| EPS Basic | -47.77% | 18.35% | 12.97% | 2.40% | 12.69% |
| Normalized Basic EPS | -18.42% | 15.47% | 9.98% | 3.21% | 48.42% |
| EPS Diluted | -47.77% | 18.35% | 12.97% | 2.40% | 13.14% |
| Normalized Diluted EPS | -18.42% | 15.47% | 9.98% | 3.21% | 48.42% |
| Average Basic Shares Outstanding | 0.00% | 0.18% | 0.25% | 0.27% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.18% | 0.25% | 0.27% | 0.00% |
| Dividend Per Share | 9.21% | -- | -- | -- | -0.99% |
| Payout Ratio | -- | -- | -0.05% | -0.16% | -- |